根据最新提交至美国证券交易委员会（SEC）的文件显示，诺和控股有限公司（Novo Holdings A/S）已完全减持其在Recursion Pharmaceuticals公司的持股。该股权变动记录截至2025年12月31日，相较于截至2025年9月30日的上一季度持股情况，诺和控股已不再持有该公司股份。
根据最新提交至美国证券交易委员会（SEC）的文件显示，诺和控股有限公司（Novo Holdings A/S）已完全减持其在Recursion Pharmaceuticals公司的持股。该股权变动记录截至2025年12月31日，相较于截至2025年9月30日的上一季度持股情况，诺和控股已不再持有该公司股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.